Frailty and cardiovascular mortality in more than 3 million US Veterans

William Shrauner1,2,3, Emily M Lord1, Xuan-Mai T Nguyen1

  • 1Massachusetts Veterans Epidemiology Research and Information Center (MAVERIC), VA Boston Healthcare System, 150 South Huntington Ave, Boston, MA 02130, USA.

European Heart Journal
|December 15, 2021
PubMed

Insights

Frailty significantly increases cardiovascular (CV) mortality risk in older adults. This risk escalates with frailty severity, independent of existing CV disease, highlighting a critical area for intervention.

Area of Science:

  • Gerontology
  • Cardiovascular Medicine
  • Public Health

Background:

  • Frailty is a known risk factor for mortality and cardiovascular (CV) events.
  • Limited contemporary data exist on frailty's impact on CV mortality in the modern era of CV prevention.

Purpose of the Study:

  • To investigate the association between frailty and CV mortality in a large cohort of older US Veterans.
  • To examine the relationship between frailty and major CV events, including myocardial infarction, stroke, and revascularization.

Main Methods:

  • Analysis of 3,068,439 US Veterans aged 65+ from 2002-2017.
  • Frailty assessed using a validated 31-item frailty index (0-1 scale).
  • Survival analysis adjusted for demographics, comorbidities, and medication use.

Main Results:

  • Frailty was associated with increased CV mortality risk across all levels of severity.
  • Increased risk observed for myocardial infarction and stroke, but not revascularization.
  • The median frailty score increased and stabilized over the study period.

Conclusions:

  • Both the presence and severity of frailty are independently linked to CV mortality in older adults.
  • Findings represent the largest and most contemporary analysis of frailty and CV mortality.
  • Further research is needed to identify strategies for mitigating frailty-related CV risk.
Abstract

Related Concept Videos

Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
82
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
96
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
45
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.2K
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
20
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
121